Endo International CEO steps down; Campanelli named successor

(Reuters) – Endo International Plc said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli, highlighting the drugmaker’s shift away from specialty branded drugs. Endo’s shares rose as much as 16 percent to $23.48 on Friday as the company also maintained its profit and revenue forecasts for the year. Campanelli joined Endo in 2015 following the company’s $8-billion acquisition of generic drugs maker Par Pharmaceutical, where he was CEO since 2012.
Go to Source

U.N. resumes Syria aid delivery after attack

By Stephanie Nebehay and Tom Miles GENEVA (Reuters) – The United Nations appealed to Syrian President Bashar al-Assad and rebel groups on Thursday to allow aid convoys to enter eastern Aleppo as U.N. relief operations in Syria resumed after a 48-hour suspension due to a deadly attack. U.N. trucks loaded with food, medical and other supplies for 35,000 people arrived in the rebel-held besieged Damascus suburb of Mouadamiya, U.N. spokesman Jens Laerke said.
Go to Source

1 31 32 33 34 35 125